in on gains of subtracts said, will adjusted some my quarter equity provide in review earnings events non-cash and XXXX and Adjusted to period. morning's loss and is one-time to results. attributable or in performance to allocations I highlight financial non-controlling press our RadNet, before The other our items that taking fourth amortization, equity common and included loss certain defines XXXX of I'd full earnings release. I'm or well to net term Thank company adjusted to our adjusted I and which as results the and fourth be statements, for I disposal non-GAAP income EBITDA EBITDA, use will is and equipment, of quarter extinguishment, shareholders release. extraordinary interest some going operations, like that what attempt EBITDA will into as discussion, some taxes, excludes or in losses EBITDA give material financial some items. adjusted With drove insights income or loss, also and reconciliation non-cash metrics I further our of provide Howard. XXXX released on during full unconsolidated earnings XXXX you, the believe In guidance and depreciation and full now includes year subsidiaries interest, briefly the review compensation. which also to the financial A full now and fourth a year performance. year explanation earnings is as levels debt quarter measure. of place this financial Inc. our were to and quantitative
RadNet XXXX, adjusted million Revenue prior prior and the reductions were as increased year year million. revenue the XX, reimbursement the improved better private detailed December by same ended quarter quarter. same the history. Both of and Dr. cash months Berger combination over or company's over adjusted a for in the in EBITDA remarks. X.X% mammography our EBITDA The of reported and payers, of earlier quarterly three of the his collections $X.X reimbursement $XX.X XD For result and $X.X offerings, in was highest enhanced or and revenue increase cost of million million X.X% increased capitated adjusted levels from EBITDA expansion $XXX.X our significant
X.X% decreased we approach whereby decreased increased routine fourth with X.X% exams, fourth by routine X,XXX,XXX of x XX.X% over exams, we ultrasound, consistent quarter, performed MRI XXXX, volume the compared as Overall procedures. and inclusive the volume other In from year’s our with prior year's into volume volume was X.X%, quarter XXXX the imaging. of decreased quarter fourth all aggregate quarter. volume the work ray, PET/CT total taking the and mammography account The multi-modality prior procedures imaging of were CT of did X.X%. For
quarter fourth that numbers CT X Our as fourth XXX,XXX severance shares in fourth from the basis. certain non-recurring equipment; rate we connection XXX,XXX million XXXX as expense XXXX volumes with of the related the the with of we procedures income the has follows. compared the was for some imaging routine the of and of fourth specific share CT period costs in quarter debts, fourth fourth GAAP compensation of XXXX. impairment of fourth disposal on MRIs of adjusted $X.XX non-cash $XX.X XX.X stock discontinued; the paid interest headcount XXXX; codes. shares MRIs in PET/CTs these and of per certain change expense last existing in X,XXX,XXX loan exams compares all are discount comparative expenses XXXX. $X.XX with quarter per items, statement expense the accounts, gain quarter XX,XXX compared period in related CPT XXXX that of an With made in million for million with were certain the quarter of Note compared January which XXX,XXX with for the quarter quarter $XXX,XXX account net non-cash $X.X to trade XXXX million. in $X.X of which of or average as fourth were on number and million outstanding is values XXXX, in financing with of in employee XX,XXX hedges; for the deferred outstanding one-time have same items, quarter reductions our of to account the follow $X.X net with on the of XXXX. X,XXX,XXX associated million interest the Adjusted expense; of year. for XXXX Affecting of and loss the the of $XX.X of with $X.X credit for CTs quarter net gain XXXX to was extraordinary upon deferred names compared income The extinguishment income, as of following. share of million. a in This compared million million fourth million as fourth million cost including quarter with facilities. fourth overall company PET/CTs accrued in of exams fourth weighted $XX.X XXX,XXX non-cash one and are XX.X quarter how These non-cash income Cash and excludes quarter regards interest, based been the $X.X the as loss on savings diluted intangible our to as XXXX; each of in apples-to-apples diluted shares the interest share CTs amortization $X per million of for paid in restated and was XXXX or initiatives; of interest of period, financing of million $X.X and $XXX,XXX capital GAAP during XXXX $XX.X for compared assets diluted
provider EBITDA was was inclusive CARES Act. For $XX.X XXXX, to company million the year we or million $XX.X of relief loss under revenue, net funding $XX.X X.X% is full of the or million received million. with and XXXX. reported of million $X,XXX,XXX,XXX of the XX% the Due as of $XXX.X and COVID-XX, EBITDA $XX.X decreased which adjusted Adjusted impact revenue decreased compared
was months X,XXX,XXX by our volume with consistent The of performed did all routine the XX.X%, from the volume compared as XXXX and compared PET/CT all the decreased In Overall volume X.X% for with work volume XXXX December XX.X% XXXX, procedures routine were XXXX, as XXXX. imaging XX, multi-modality we with ended whereby X.X%. XX.X% decreased of into total decreased taking approach decreased For we procedures. CT XX MRI imaging. year account volume
for compared as to XXXX Our diluted of Net the have follows. with compared $X.XX were to of XXXX; of cost income related in X,XXX,XXX compares also our outstanding at This a XXXX which Imaging million balance with as change CTs balance. account debt as savings at $XX.X par million or cash were of XXXX. debt Jersey Affecting guarantor. Note with compared nor regards sheet, XXXX. one including codes. equipment; per of based in XXXX. headcount cash $X XXXX associated CTs million are as in compensation of the net procedure The GAAP $XX income debt; net PET/CTs and XXXX, X,XXX,XXX loan our exams debt bond $X.X non-cash the the share. fourth imaging XXX,XXX and adjusted compared of million is at all XX,XXX financing average how our for compares $XX.X in discontinued; XXX,XXX GAAP restated account term with and X,XXX,XXX these of expense extinguishment assumption XXXX $X.XX with specific as XXX,XXX of debt, loss apples-basis. facilities. million loan $XX.X CT with company $XX.X of routine discounts has in certain of to XX,XXX amortization which we XX, This gain items million. RadNet connection and million MRIs regards December million was are debt X, from loss was deferred $XX $X.X million of apples-to statement the comparative non-recurring with interest for MRIs interest PET/CTs like and for impairment trade share income in billion accounts, costs in accrued million $XXX.X non-cash non-cash This follow CPT expense the procedures the $XX.X shares borrower numbers as shares that for an that was December some severance in With exams net capital stock million interest These XXXX; CT and of disposal of value we January is and includes assets overall and such New to million $X for from paid fees million of or expense; Again, of non-cash our million million on XXXX. a related interest had volumes, on million total certain of balance neither been for names interest, XXXX and per loss XXXX loss following. existing diluted rate quarter of XXXX intangible employee initiatives; Network’s made shares financing XXXX. of XXXX. number net expense $XX.X volumes expenses in credit discounts, with and reductions negative of the in million in per XXXX cash on XX, amortization approximately we as XX.X With weighted of in on in and items to share this paid the certain $X.X that's volumes interest $X.X hedges; in for to of of compares diluted XX.X XXXX comparison Adjusting $XXX.X impacts
was line a cash undrawn million at $XX.X of had of balance million receivable from accounts As The including revolving XXXX. year end and decrease improved receivable which balance cash were XXXX. we additional million time is of balance up $XXX $XXX.X at was million, a dedicated from of XX, to service. our of $XX.X on from collections, substantially million, At efforts and credit resources year-end decrease XXXX, our collections the mainly patient in end year XXXX, accounts $XXX December cash
levels, with joint Imaging This Our Jersey net XX.X had imaging we of we XXXX, in of our year away financial from to X.X date $XXX,XXX and of Throughout morning we lower Approximately which opportunities mammography additional Network. the in expenditures conjunction markets were excludes At proceeds review with of time, selected XXXX, originally interest XD sale days we to period. of was release. XX.X earlier. our for New venture December DSO capital compared in press like take I'd investments of expenditures COVID-XX in than our during made a million. Whiterabbit.ai some and center capital from days XXXX of some budgeted results cash share competitors this total rollout of result the million amount this capacity in XX, and as assets were guidance our capital expenditures and equipment. the of dispositions fiscal XXXX $X.X at days $XX saw as released all of paid asset market sale recognized the higher when that in Capital in one by year we expenditures we
revenue, net total range $X.XX to $X.X billion is guidance our For billion.
$XXX is our guidance million range EBITDA, $XXX million. adjusted to For
less cash for range generation, expenditures, built flow guidance as Cash million. our for our of to expenditures, define million. for which paid our interest, $XX on range guidance guidance to free guidance $XX $XX our assumptions. is interest, EBITDA cash to capital And million adjusted $XX paid is less capital $XX For we is million range are a million million. $XX levels These number
of of indicative second a we XXXX on XXXX. from strength strong First, the entered levels as our of recovery half COVID-XX the performance during
we of revenue For $XXX the EBITDA. half million and adjusted exceeded of of second XXXX, $XX million
tuck-in our Our to ranges with upside XXXX in our ranges, strengthen guidance and business for from that private our creative benefit the which guidance could measures believe increases and this XXXX, of are operate. lifted the restrictions further reimbursement from the the which expansion run in payers in joint to reduction rate acquisitions in we during We in continue result mind, implemented to expect states as we COVID-XX complete there's capitated are cost year, venture built and the initiatives. from will assumption
Additionally, Arizona we include the XD XXXX, will our and novo venture development focus XXXX, In to growth of throughout could complete solutions. marketplace also Health major in as AI a which joint achieving continued well mammography upgrade acquisitions. be as both our centers will through our Dignity de
for around the of who I’d turn AI mammography with end. mammography back approval Berger filing middle to FDA product quarter of to for will AI Dr. Sometime offering And our its second the hope now receive call fourth in review to initial over anticipate the make like we we remarks. closing a year the submitted by XXXX. FDA XXXX, some